← Back to all trials
Recruiting
NCT07725146
Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire
Conditions: Lipedema
Sex: Female
Ages: 18 Years – 75 Years
Healthy volunteers: No
Enrollment: 180
Sponsor: Marmara University
Location: Sultan 2. Abdülhamid Han Training and Research Hospital, Physical Medicine and Rehabilitation Clinic, Istanbul, Turkey. Istanbul Kadıköy
Summary
Lipedema is a chronic disease characterized by abnormal fat accumulation, primarily in the lower extremities, affecting women. This study aims to evaluate the validity and reliability of the Turkish version of the Rapprich Lipedema Symptomatic Assessment Questionnaire, which was originally developed by Rapprich et al. in 2010. Since a validated Turkish version is currently unavailable, this research will provide a standardized tool for clinicians to assess symptomatic severity in Turkish-speaking lipedema patients.
Eligibility Criteria
Inclusion Criteria:
* Female patients aged 18-75.
* Diagnosed with lipedema by a clinician.
* Willingness to participate and sign the informed consent form.
Exclusion Criteria:
* Positive Stemmer sign or presence of advanced-stage lymphedema.
* Diagnosis of Heart Failure.
* Chronic Kidney Disease.
* Pregnancy.
* BMI \> 50 kg/m².
Source: ClinicalTrials.gov (NCT07725146). StuddyBuddy aggregates publicly available trial information.